Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Microsaic Systems Appoints Colin Jump as New CEO

Published: Tuesday, November 06, 2012
Last Updated: Tuesday, November 06, 2012
Bookmark and Share
Company to drive the commercialization of its revolutionary chip-based technology.

With over 30 years of experience working in the analytical instrumentation sector, Colin has a proven track record helping companies to achieve significant growth and will bring a vast amount of commercial and operational acumen to the role.

Prior to joining Microsaic, Colin was responsible for developing and growing Shimadzu UK Ltd, a global manufacturer of scientific research instruments.

As UK Managing Director of Shimadzu UK Ltd for the past 11 years, Colin led the company using his extensive business experience and industry knowledge to implement comprehensive growth and marketing communication strategies, both of which will be invaluable in the development and growth of Microsaic Systems going forward.

Before managing Shimadzu UK Ltd, Colin was European Commercial Director at SGE Europe Ltd, which followed seven years in senior management and marketing positions at Mallinckrodt Baker in the UK and the Netherlands.

In addition, his prior roles in sales and marketing positions at Bayer Diagnostics, Boehringer Mannheim UK and Wellcome Diagnostics will undoubtedly be beneficial to Mircosaic Systems as it looks to establish its innovative chip-based scientific instruments within the analytical instrumentation market.

“Microsaic Systems is the first and only company to have commercialized MS (mass spectrometry) technology on a chip,” said Colin Jump.

“This places the company in an optimal position to deliver this gold standard technique for chemical analysis to a much wider range of users and applications.”

He continues, “I am excited to be joining Microsaic Systems at this crucial stage as it accelerates the commercialization of its revolutionary chip-based technology. With the ability to address major opportunities across multiple market areas I see huge potential for the technology and for the Company in the years ahead.”

“Our breakthrough product, the 3500 MiD, represents a step change in the ease of use and footprint of mass spectrometry. The instrument is smaller, lighter, consumes less energy, is easier to maintain and cheaper to run than conventional MS systems,” comments Eric Yeatman, Acting CEO of Microsaic Systems.

Yeatman continued, “The Board is very pleased to welcome Colin Jump to the company as our new CEO and I have no doubt his commercial and operational experience in the analytical instrumentation sector will help drive the business forward towards the further realization of our corporate goals.”

The 3500 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection.

Its low operating cost and small footprint make the 3500 MiD deployable in a wide range of applications where mass spectrometry has not been able to reach - until now.

Colin Jump will take up his role on 5th November 2012, at which point Eric Yeatman and Colin Nicholl will resume their former roles as Chairman and Deputy Chairman, respectively.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Microsaic Systems Signs Commercial Agreement
Second major agreement for novel miniaturized chip-based scientific instrument.
Thursday, April 11, 2013
Microsaic Systems Wins R&D 100 Award for the World’s Most Compact Mass Spectrometer
Microsaic’s 3500 MiD mass spectrometer has been chosen winner by an independent judging panel and the editors of R&D Magazine.
Friday, June 22, 2012
Microsaic Systems Appoint Sales and Marketing Manager
Microsaic Systems plc announces that Samantha Dunnage has joined to lead the Company’s marketing and direct sales.
Monday, August 08, 2011
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Acetaldehyde and Formaldehyde Content in Foods
Korean researchers have determined the content of the toxic and carcinogenic aldehydes, acetaldehyde and formaldehyde, in a variety of food groups.
Combining the Power of Mass Spectrometry & Microscopy
A tool that provides world-class microscopy and spatially resolved chemical analysis shows considerable promise for advancing a number of areas of study, including chemical science, pharmaceutical development and disease progression.
Increasing Vitamin D Supplementation
New study from ETH Zurich finds that elderly women should consume more vitamin D than previously recommended during the winter months.
Advancing Lithium-Ion Battery Research
The increasing number of components in a lithium-ion battery makes it essential to use a variety of analytical methods to attain complete characterization.
Clearest Ever Images of Enzyme that Plays Key Roles in Aging, Cancer
UCLA-led research on telomerase could lead to new strategies for treating disease
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos